Viewing nowNexialdi 40 mg (Esomeprazole Magnesium Trihydrate)
Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
JW Pharmaceutical Co., Ltd.

MFDS item code 201507478 · Approved 2015.10.30 · Insurance code 644102820
Treatment and prevention of reflux and hyperacidity, ulcers, and drug-induced gastrointestinal symptoms; Helicobacter eradication therapy
This medicine is used for the treatment of gastroesophageal reflux disease, maintenance therapy to prevent recurrence of erosive reflux esophagitis, and relief of symptoms of gastroesophageal reflux disease without esophagitis. It is also effective for the treatment and prevention of duodenal ulcers and peptic ulcers as part of an antibiotic regimen for Helicobacter pylori eradication. It is used short-term in the treatment of upper gastrointestinal symptoms related to non-steroidal anti-inflammatory drugs and is applicable for the treatment and prevention of gastric ulcers. Furthermore, it is used for the treatment of Zollinger-Ellison syndrome and the prevention and maintenance therapy of rebleeding from gastric or duodenal ulcers. It helps improve various gastrointestinal diseases and ulcer-related symptoms.
This medicine should be swallowed with a liquid such as water and should not be chewed or crushed. Adults Gastroesophageal reflux disease (GERD) Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. For patients whose esophagitis has not healed or whose symptoms persist, continue treatment for an additional 4 weeks. Long-term maintenance therapy to prevent recurrence in patients with esophagitis: 20 mg once daily Symptomatic treatment of gastroesophageal reflux disease without esophagitis: 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. Once symptoms have resolved, control subsequent recurring symptoms by administering 20 mg once daily. In adults, 20 mg may be administered once daily as needed. As-needed administration to control recurring symptoms is not recommended for patients at high risk of developing gastric or duodenal ulcers due to treatment with nonsteroidal anti-inflammatory drugs. Combination therapy with antibiotics for Helicobacter pylori eradication Administer this medicine 20 mg in combination with amoxicillin 1 g and clarithromycin 500 mg twice daily for 7 days. Short-term treatment of upper gastrointestinal symptoms (pain, discomfort, burning) associated with administration of nonsteroidal anti-inflammatory drugs (nonselective or selective COX-2 inhibitors) 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. Clinical trials lasting more than 4 weeks have not been conducted. Patients requiring continued treatment with nonsteroidal anti-inflammatory drugs Treatment of gastric ulcers associated with administration of nonsteroidal anti-inflammatory drugs: 20 mg once daily. The treatment period is 4∼8 weeks. Prevention of gastric and duodenal ulcers associated with administration of nonsteroidal anti-inflammatory drugs: 20 mg once daily. Treatment of Zollinger-Ellison syndrome The recommended initial dose is 40 mg twice daily. The dose should then be adjusted for each patient, and treatment should continue while clinical symptoms are present. Clinical data indicate that most patients can be controlled with doses of 80 ∼ 160 mg daily. Doses greater than 80 mg daily should be divided into 2 doses per day. Maintenance therapy following initiation of prevention of recurrent bleeding from gastric or duodenal ulcers by intravenous administration Administer 40 mg once daily for 4 weeks following initiation of prevention of recurrent bleeding from gastric or duodenal ulcers by intravenous administration. Renal impairment No dosage adjustment is necessary. Use with caution because there is limited experience administering this medicine to patients with severe renal failure. Hepatic impairment No dosage adjustment is necessary in patients with mild to moderate hepatic impairment. In patients with severe hepatic impairment, the dose of this medicine should not exceed 20 mg. Elderly patients No dosage adjustment is necessary.
Adolescents 12 years and older — Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. For patients whose esophagitis has not healed or whose symptoms persist, continue treatment for an additional 4 weeks. Adolescents 12 years and older — Symptomatic treatment of gastroesophageal reflux disease without esophagitis: 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. Adolescents 12 years and older — Once symptoms have resolved, control subsequent recurring symptoms by administering 20 mg once daily. Adolescents 12 years and older — In adults, 20 mg may be administered once daily as needed. As-needed administration to control recurring symptoms is not recommended for patients at high risk of developing gastric or duodenal ulcers due to treatment with nonsteroidal anti-inflammatory drugs. Children under 12 years — There is no experience with administering this medicine to children under 12 years.
This medication should not be administered to certain patients. For example, patients who are allergic to this drug or its components, those who have had hypersensitivity reactions to benzimidazoles in the past, patients allergic to penicillins or macrolide antibiotics, patients taking specific heart-related medications, women who are breastfeeding, and patients with a history of myocardial infarction should not use this medication. Caution is required as various adverse reactions may occur during the use of this medication. Common side effects may include headache, abdominal pain, diarrhea, constipation, and nausea, while rare but serious side effects such as blood abnormalities, hypersensitivity reactions, hypomagnesemia, mental confusion, liver function abnormalities, and skin rashes have also been reported. If symptoms like muscle pain or weakness appear, consult a healthcare professional immediately. Regular check-ups are necessary for long-term use of this medication, and if symptoms suggesting a malignant tumor arise, a doctor's diagnosis must be obtained. Additionally, as the medication lowers gastric acidity, it may increase the risk of certain bacterial infections, so inform a healthcare provider if diarrhea persists. This medication interacts with many other drugs, so be sure to inform your physician or pharmacist if you are taking any other medications. Caution is especially necessary when combined with antiviral agents, anticoagulants, or anticonvulsants, as the effects of some medications may change. The safety of this medication during pregnancy has not been fully established, so it should only be taken as per a physician's judgment when absolutely necessary, and its use should be avoided while breastfeeding. In case of overdose, there is no specific antidote, so seek appropriate treatment at a medical institution immediately, and it is important to provide symptomatic treatment as the drug cannot be removed by dialysis. Finally, this medication should be stored out of the reach of children, and care must be taken to avoid transferring it to another container as this may compromise its quality.
Leukopenia, thrombocytopenia, agranulocytosis, pancytopenia, fever, angioedema, anaphylactic reaction, shock, peripheral edema, hyponatremia, hypomagnesemia, insomnia, anxiety, mental confusion, depression, aggression, hallucinations, headache, dizziness, paresthesia, drowsiness, taste disturbance, blurred vision, bronchospasm, pancreatitis, abdominal pain, constipation, diarrhea, abdominal bloating, nausea, vomiting, dry mouth, stomatitis, gastrointestinal candidiasis, microscopic colitis, elevated liver enzymes, hepatitis, jaundice, liver failure, encephalopathy, dermatitis, itching, rash, urticaria, hair loss, photosensitivity, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, acute generalized exanthematous pustulosis, eosinophilia with systemic symptoms drug reaction, fracture, arthralgia, myalgia, muscle weakness, interstitial nephritis, gynecomastia, asthenia, increased sweating, Clostridium difficile-associated diarrhea, abdominal distension, allergic reaction, back pain, chest pain, sternal pain, facial edema, facial flushing, fatigue, fever, influenza-like illness, generalized edema, leg edema, malaise, pain, stiffness, anemia, hypopigmented anemia, cervical lymphadenopathy, nosebleed, leukocytosis, leukopenia, thrombocytopenia, hyperbilirubinemia, liver dysfunction, increased ALT, increased AST, diabetes, hyperuricemia, increased ALP, polydipsia, vitamin B12 deficiency, weight gain, weight loss, aggravated arthritis, arthropathy, convulsions, fibromyalgia syndrome, hernia, rheumatic polymyalgia, anorexia, apathy, increased appetite, confusion, worsened depression, hypertonia, sensory impairment, erectile dysfunction, insomnia, migraine, worsened migraine, sleep disorder, tremor, visual field loss, dysmenorrhea, menstrual disorders, vaginitis, exacerbated asthma, cough, dyspnea, laryngeal edema, pharyngitis, rhinitis, sinusitis, acne, pruritus ani, erythematous rash, papular rash, otitis media, abnormal olfaction, loss of taste, taste distortion, urinary abnormalities, albuminuria, cystitis, dysuria, fungal infection, hematuria, urinary frequency, candidiasis, genital candidiasis, polyuria, conjunctivitis, visual disturbances, duodenitis, esophagitis, esophageal stricture, esophageal ulcer, esophageal varices, gastric ulcer, gastritis, benign polyp or nodule, Barrett's esophagus, mucosal pigmentation, hernia, systemic lupus erythematosus, cutaneous lupus erythematosus, gastric fundus polyp, hypocalcemia, hypokalemia, rhabdomyolysis
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to avoid exposure to air or moisture. It is advisable to maintain the storage temperature between 1 and 30 degrees Celsius.
Pink, round film-coated tablet
28 tablets/box [(14 tablets/PTP x 2)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowEsomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
JW Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Dihydrate 43.38mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Esomeprazole Magnesium Dihydrate 21.69mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.